In recent decades, abnormalities in the expression and production of IL-32 have been identified in many human disorders such as rheumatoid arthritis, various cancers, pulmonary tuberculosis, atopic dermatitis, leishmaniasis, etc. [21,22,23,24,25,26,27,28,29,30]. This evidence concerns the gene IL32 and cancer.